FDA Inspection 732115 — Quadex Pharmaceuticals, Llc

Quadex Pharmaceuticals, Llc — FEI 3003005746

The FDA completed an inspection of Quadex Pharmaceuticals, Llc on June 28, 2011 in South Jordan, UT. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 28, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
South Jordan, UT (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
194321 CFR 211.180(e)(1)Review of representative number of batches
363921 CFR 211.204Returned drug procedures in writing and followed
364121 CFR 211.204Record information inclusions
439121 CFR 211.180(e)(2)Items to cover on annual reviews